On May 10, 2023, PharmaCyte Biotech, Inc., closed the transaction. The company has raised a total of $35 million in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | +0.47% | -4.50% | -1.85% |
- We are working hard to come back as soon as possible.
- Nous travaillons dur pour revenir au plus vite.
- Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
- Estamos trabajando duro para volver lo antes posible.
- Stiamo lavorando sodo per tornare il prima possibile.
- Wij werken hard om zo snel mogelijk weer terug te zijn.
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.85% | 17.92M | |
+26.47% | 664B | |
+25.70% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.42% | 234B | |
+4.71% | 199B | |
-10.10% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. announced that it has received $35 million in funding